Skip to main content
Caplight Logo









Cambiotics

Cambiotics

Private
CopenhagenHealthcare & Life Scienceshttps://cambiotics.com/

Last Round

Seed

Feb 2, 2026

Total Funding Raised

$5.26M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cambiotics is a biotechnology company developing a precision probiotic designed to help the body remove PFAS (per- and polyfluorinated alkyl substances), also known as 'forever chemicals'.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2C

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Non-AI

Keywords

PFAS blood testPFAS testinggut healthprobiotic supplementbiohackingdiagnostic testinghealth optimizationenvironmental healthdirect-to-consumer healthmicrobiome researchDTC healthwellness programper- and polyfluoroalkyl substancesPFAS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cambiotics Comparables

Compare Cambiotics with similar companies based on industry and business-model similarity.

Cambiotics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Relentless Health
83%
Eurofins Scientific SE
77%
Quest Diagnostics
66%

Cambiotics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 2, 2026
AcceleratorFeb 29, 2024

Cambiotics Investors

Notable investors and investment history

Cambiotics investors
InvestorRounds
TrueSeed
Collaborative FundSeed
Cambridge EnterpriseAccelerator
The Export and Investment Fund of DenmarkSeed
True GlobalSeed
BioInnovation InstituteAccelerator, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 39% MoM, reaching 3.2K.

  • Jul 26, 2026

    Monthly visitors increased 78% MoM, reaching 2.3K.

Recent news

Latest coverage and updates

  • launchesJun 16, 2026

    Cambiotics ApS launched 46&, a revolutionary dietary supplement on Jun 1st '26.

Cambiotics Filings

Explore SEC and related filing metadata, where available.

Cambiotics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cambiotics's valuation, stock price, and market status.

Is Cambiotics a public or private company?

Cambiotics is a private company.

What is the current stock price of Cambiotics?

Cambiotics is a private company with no public stock price. No recent secondary market data is available.

How much is Cambiotics worth (valuation)?

Valuation information for Cambiotics is not publicly available.

Can I buy Cambiotics stock?

Cambiotics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cambiotics's last funding round?

Cambiotics's most recent funding round was Seed on February 11, 2026.

Who are the main investors in Cambiotics?

Key investors in Cambiotics include Collaborative Fund.

Will Cambiotics IPO soon?

No public IPO plans have been announced for Cambiotics.

How can I track Cambiotics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cambiotics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCopenhagen
Employee Range9
Year Founded2024
Last FundingFeb 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?